The results of immunohistochemical analysis also showed that after miR-16-5p treatment the expression levels of YTHDF1 and PKM2 in tumor tissues were significantly down-regulated, indicating that miR-16-5p can selectively target the YTHDF1-PKM2 signal axis to inhibit tumor growth. Here, PKM is linked to neoplasm.